These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 16113984)

  • 1. Virology--11th international congress. 9-13 August 1999, Sydney, Australia.
    Fooks A
    IDrugs; 1999 Nov; 2(11):1136-8. PubMed ID: 16113984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of an attenuated H5N1 avian influenza virus vaccine with all eight genes from avian viruses.
    Shi H; Liu XF; Zhang X; Chen S; Sun L; Lu J
    Vaccine; 2007 Oct; 25(42):7379-84. PubMed ID: 17870216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccines and viral antigenic diversity.
    Mumford JA
    Rev Sci Tech; 2007 Apr; 26(1):69-90. PubMed ID: 17633294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Various sides of influenza. Part II--epidemiology, influenza surveillance and prophylaxis].
    Machała MK; Brydak LB
    Pol Merkur Lekarski; 2006 Sep; 21(123):277-85. PubMed ID: 17163191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucosal immunization using recombinant plant-based oral vaccines.
    Streatfield SJ
    Methods; 2006 Feb; 38(2):150-7. PubMed ID: 16431131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotypic properties resulting from directed gene segment reassortment between wild-type A/Sydney/5/97 influenza virus and the live attenuated vaccine strain.
    Parks CL; Latham T; Cahill A; O'neill RE; Passarotti CJ; Buonagurio DA; Bechert TM; D'Arco GA; Neumann G; Destefano J; Arendt HE; Obregon J; Shutyak L; Hamm S; Sidhu MS; Zamb TJ; Udem SA
    Virology; 2007 Oct; 367(2):275-87. PubMed ID: 17599381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The development and characterization of H5 influenza virus vaccines derived from a 2003 human isolate.
    Horimoto T; Takada A; Fujii K; Goto H; Hatta M; Watanabe S; Iwatsuki-Horimoto K; Ito M; Tagawa-Sakai Y; Yamada S; Ito H; Ito T; Imai M; Itamura S; Odagiri T; Tashiro M; Lim W; Guan Y; Peiris M; Kawaoka Y
    Vaccine; 2006 Apr; 24(17):3669-76. PubMed ID: 16378663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Developments towards effective treatments for Nipah and Hendra virus infection.
    Bossart KN; Broder CC
    Expert Rev Anti Infect Ther; 2006 Feb; 4(1):43-55. PubMed ID: 16441208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent progress in henipavirus research.
    Halpin K; Mungall BA
    Comp Immunol Microbiol Infect Dis; 2007 Sep; 30(5-6):287-307. PubMed ID: 17629946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. M2e-based universal influenza A vaccine.
    Fiers W; De Filette M; El Bakkouri K; Schepens B; Roose K; Schotsaert M; Birkett A; Saelens X
    Vaccine; 2009 Oct; 27(45):6280-3. PubMed ID: 19840661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Research and development strategies, examples among new vaccines].
    Denis F; Ploy MC
    Ann Pharm Fr; 2009 May; 67(3):198-202. PubMed ID: 19446670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infectious clone-derived viruses from virulent and vaccine strains of porcine reproductive and respiratory syndrome virus mimic biological properties of their parental viruses in a pregnant sow model.
    Kwon B; Ansari IH; Osorio FA; Pattnaik AK
    Vaccine; 2006 Nov; 24(49-50):7071-80. PubMed ID: 17049689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New viral vaccines.
    Arvin AM; Greenberg HB
    Virology; 2006 Jan; 344(1):240-9. PubMed ID: 16364754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative efficacy of North American and antigenically matched reverse genetics derived H5N9 DIVA marker vaccines against highly pathogenic Asian H5N1 avian influenza viruses in chickens.
    Jadhao SJ; Lee CW; Sylte M; Suarez DL
    Vaccine; 2009 Oct; 27(44):6247-60. PubMed ID: 19686695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Level of protection of chickens against highly pathogenic H5 avian influenza virus with Newcastle disease virus based live attenuated vector vaccine depends on homology of H5 sequence between vaccine and challenge virus.
    Römer-Oberdörfer A; Veits J; Helferich D; Mettenleiter TC
    Vaccine; 2008 May; 26(19):2307-13. PubMed ID: 18395947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Research advances on transgenic plant vaccines.
    Han M; Su T; Zu YG; An ZG
    Yi Chuan Xue Bao; 2006 Apr; 33(4):285-93. PubMed ID: 16625826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The emergence of Nipah virus, a highly pathogenic paramyxovirus.
    Lo MK; Rota PA
    J Clin Virol; 2008 Dec; 43(4):396-400. PubMed ID: 18835214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Swine influenza viruses a North American perspective.
    Vincent AL; Ma W; Lager KM; Janke BH; Richt JA
    Adv Virus Res; 2008; 72():127-54. PubMed ID: 19081490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.